Group 1 - The core viewpoint of the article highlights the healthcare sector's shift towards ending the "low-price bidding" mechanism in procurement, which is expected to halt the drastic price declines in the industry [1] - The medical device sector has seen price reductions from collective procurement affecting low-value consumables, but a specific company has established a defense against low-price "dumping" through product iteration, positioning itself as a potential benchmark for cyclical recovery [1] - The medical equipment industry is driven by high-end breakthroughs and a recovery in bidding processes, with companies already achieving performance rebounds through advancements in high-end technology [1]